U.S. Markets close in 1 hr 55 mins

Relay Therapeutics, Inc. (RLAY)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
15.85+0.85 (+5.67%)
As of 02:05PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close15.00
Bid15.73 x 800
Ask15.75 x 800
Day's Range15.00 - 15.85
52 Week Range12.65 - 35.36
Avg. Volume1,261,110
Market Cap1.916B
Beta (5Y Monthly)1.25
PE Ratio (TTM)N/A
EPS (TTM)-2.84
Earnings DateMay 03, 2023 - May 08, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est35.00
  • GlobeNewswire

    Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR

    Relay Therapeutics to host conference call following AACR presentationCAMBRIDGE, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that initial clinical data from the ReDiscover trial for RLY-2608 have been selected for presentation at the upcoming American Association for Cancer Research (AACR)

  • GlobeNewswire

    Relay Therapeutics to Participate in Two Upcoming Investor Conferences

    CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in two fireside chats this month, at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 10:30 a.m. ET and the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:05 p.m. ET. The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following

  • Simply Wall St.

    Relay Therapeutics Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag

    Relay Therapeutics ( NASDAQ:RLAY ) Full Year 2022 Results Key Financial Results Net loss: US$290.5m (loss narrowed by...